[PDF] Leading Biotechnology Alliances - eBooks Review

Leading Biotechnology Alliances


Leading Biotechnology Alliances
DOWNLOAD

Download Leading Biotechnology Alliances PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Leading Biotechnology Alliances book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page



Leading Biotechnology Alliances


Leading Biotechnology Alliances
DOWNLOAD
Author : Alice M. Sapienza
language : en
Publisher: Wiley-Liss
Release Date : 2001-04-09

Leading Biotechnology Alliances written by Alice M. Sapienza and has been published by Wiley-Liss this book supported file pdf, txt, epub, kindle and other format this book has been release on 2001-04-09 with Business & Economics categories.


Nearly all pharmaceutical and biotechnology companies are forming strategic alliances, presenting formidable management challenges. "Leading Biotechnology Alliances: Right from the Start" provides immediately applicable tools for managing human relationships involved in these strategic alliances.



From Breakthrough To Blockbuster


From Breakthrough To Blockbuster
DOWNLOAD
Author : Donald L. Drakeman
language : en
Publisher: Oxford University Press
Release Date : 2022

From Breakthrough To Blockbuster written by Donald L. Drakeman and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2022 with Biotechnology industries categories.


"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--



Strategic Alliances In Biotechnology And Pharmaceuticals


Strategic Alliances In Biotechnology And Pharmaceuticals
DOWNLOAD
Author : Hans-Werner Gottinger
language : en
Publisher:
Release Date : 2010

Strategic Alliances In Biotechnology And Pharmaceuticals written by Hans-Werner Gottinger and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010 with Alliances stratégiques (Affaires). categories.


This book covers a strategic industry analysis of a globally operating pharmaceutical and biotechnology industry. Both biotechnology and large pharmaceutical firms compete in a network industry characterised by rapid technological change which leads to industry change and market structure. In particular, these firms depend on the creation of new knowledge. New knowledge presents particular issues regarding transferability. Innovation potentials and alliance competencies should be prevalent in any market characterised by fast changing intangible assets , given the difficulties in trading intangibles; moreover, in industries with very high rates of technology change, technologies can be introduced that create new market segments, obsolesce existing product lines, and create substantial competitors from previously little-known firms.



Collaborative Value Creation


Collaborative Value Creation
DOWNLOAD
Author : Hady Farag
language : en
Publisher: Springer Science & Business Media
Release Date : 2009-06-12

Collaborative Value Creation written by Hady Farag and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009-06-12 with Business & Economics categories.


Collaboration plays an important role in the early development of com- nies. Among others, they provide opportunities to combine complementary resources, develop additional competencies, and generate valuable signals for investors. They are particularly important for biotechnology firms, whose resource base often is not sufficient to realize the market potential of their R&D findings. Strategic alliances thus are an integral part of the business model of most biotechnology companies, but their economic re- vance is not yet fully understood, since research has thus far neglected most industry-specific drivers of alliance value. Based on an event study, Hady Farag analyzes the capital-market re- tion to alliance-related news announcements and assesses their complex - fects on company value. In this regard, the present work represents the first comprehensive study of European biotechnology alliances. In addition to this unique database, the research approach and techniques in sample - lection, econometric and cross-sectional analyses are state-of-the-art. The author develops and empirically tests an integrative dynamic model of collaborative value drivers. These reflect the specific characteristics of biotechnology firms and biotechnology alliances. Moreover, the work - tends to so far entirely unresearched dynamic aspects of alliances, such as the value of contractual flexibilities, the impact of environmental unc- tainty, and the evolution of alliances over time. Overall, Hady Farag’s work underscores the need to consider pluralistic influences on the value of collaborative ventures.



Biotech Pharmaceutical Alliances As A Signal Of Asset And Firm Quality


Biotech Pharmaceutical Alliances As A Signal Of Asset And Firm Quality
DOWNLOAD
Author : Sean Nicholson
language : en
Publisher:
Release Date : 2002

Biotech Pharmaceutical Alliances As A Signal Of Asset And Firm Quality written by Sean Nicholson and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2002 with Biotechnology industries categories.


Examines the determinants of biotech-pharmaceutical deal prices.



Knowledge Spillovers In Strategic Alliances


Knowledge Spillovers In Strategic Alliances
DOWNLOAD
Author : Suzanne E. Majewski
language : en
Publisher:
Release Date : 2002

Knowledge Spillovers In Strategic Alliances written by Suzanne E. Majewski and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2002 with Biotechnology industries categories.




Biotechnology Deals


Biotechnology Deals
DOWNLOAD
Author :
language : en
Publisher:
Release Date : 2005

Biotechnology Deals written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2005 with Biotechnology industries categories.


Inside the Minds: Biotechnology Deals is an authoritative, insider's perspective on the issues surrounding biotech deals, including mergers and acquisitions, collaborations, and the future of doing successful deals. Featuring lawyers, CEOs of funded biotech companies, and venture capitalists who invest in them, this book provides a broad, yet comprehensive overview of the art of doing successful deals from the experts themselves. From finding and capitalizing on opportunities to completing the deal, these authors articulate the finer points around doing biotech deals now and what will hold true into the future. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today as experts offer up their thoughts around the keys to success within this fascinating area.About Inside the Minds:Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book.This book is by: Lee R. Brettman, M.D., FACP, Dynogen Pharmaceuticals, Inc.??Successful Strategies for Biotech Deals?Manish N Chapekar, Montreux Equity Partners??Building Successful Biotech Deals?Daniel Devine, Acceptys, Inc.??The Art of the Deal?Mark I. Gruhin, Schmeltzer, Aptaker & Shepard, PC??Mergers and Acquisitions, Collaborations, and Partnerships?James T. Gunton, NJTC Venture Fund??Strategies for Successful Deals?Johnny Humphreys, Gen Prime??Finding Success in Biotech?Roland H. Johnson, Piedmont Pharmaceuticals LLC??Making Your Way Through Biotech Dealings?Thomas G. Klopack, Self Employed, Former CEO of Aclara Biosciences??Keys to Success in Biotechnology?Gerard J. McGarrity, Ph.D., Intronn Inc.??Successful Biotech Deals?Mark Schwartz , Ph.D., Bayhill Therapeutics??Biotech Deal Strategies?Abhi-Shek Jain, WTP Capital, LLC??Secrets to Success?Alexis V. Lukianov, NuVasive, Inc.??Finding and Capitalizing on Opportunities?



Strategic Alliances Between Large And Small Research Intensive Organizations


Strategic Alliances Between Large And Small Research Intensive Organizations
DOWNLOAD
Author : M.J.C. Martin
language : en
Publisher:
Release Date : 2014

Strategic Alliances Between Large And Small Research Intensive Organizations written by M.J.C. Martin and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014 with categories.


Studies strategic alliances between small and large North American biotechnology firms. A strategic alliance (SA) is defined as a short- or long-term collaboration between firms, involving partial or contractual ownership. The most common SA is between small and large firms: large firms have the resources to give small, innovative firms the competitive advantage they need, and small firms have specialized knowledge to provide to large firms a "window on new technology." SAs are often established to combat increasing international competition, though alliances are also being made between Japanese, European, and American companies. To examine SAs among research-intensive firms, questionnaires were mailed to senior executives of selected North American companies: 42 out of 144 dedicated biotechnology companies (DBCs) and 21 out of 70 large biotechnology firms responded. Additionally, in-depth interviews with some 30 large and small companies investigated SA networks, success rate, establishment process and negotiation. According to this research, SAs were most often initialized in the early stages of the innovation process as a means of gaining resources. The most important SAs for large firms were technology based, while small firms initiated SAs to gain financial advantages. For example, a case study on T-Cell Sciences shows that its alliance with Pfizer, a large pharmaceutical company, funds product development and market access, so that the company is able to expand its proprietary technology base. The study concludes that SAs vary with the life cycle of the company, but typically continue to be beneficial among small and large firms willing to spend the time and effort to establish and sustain them. (CJC).



Causes And Consequences Of Strategic Alliance Formation


Causes And Consequences Of Strategic Alliance Formation
DOWNLOAD
Author : Suzanne Ellen Majewski
language : en
Publisher:
Release Date : 1998

Causes And Consequences Of Strategic Alliance Formation written by Suzanne Ellen Majewski and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1998 with Biotechnology industries categories.




The Biotechnology Business


The Biotechnology Business
DOWNLOAD
Author : Peter Daly
language : en
Publisher: Rowman & Littlefield Publishers
Release Date : 1985

The Biotechnology Business written by Peter Daly and has been published by Rowman & Littlefield Publishers this book supported file pdf, txt, epub, kindle and other format this book has been release on 1985 with Business & Economics categories.


This comprehensive analysis is concerned with the forces shaping industry structure, as well as with the strategic responses, options and constraints affecting both the new biotechnology firms and established firms such as pharmaceutical multinationals. Beginning with a non-technical introduction to biotechnology and its applications, the author describes the types of companies involved in the commercialization of biotechnology and how they are financed. He then analyzes the special relationship between science and technology, the role of national governments, and such factors as entry barriers and technological uncertainty.